MDR Vivacit-E Elevated Study

Part of paid clinical trials in South Bend, Indiana.

Sponsor
Zimmer Biomet
Study ID
NCT07150221
Status
Enrolling By Invitation

Conditions

  • Avascular Necrosis of Bone of Hip
  • Diastrophic Variant
  • Fracture of Pelvis
  • Fused Hip
  • Osteoarthritis (OA) of the Hip
  • Protrusio Acetabuli
  • Slipped Capital Femoral Epiphyses
  • Traumatic Arthropathy-Hip

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Vivacit-E Elevated Liners — DEVICE
    Primary total hip arthroplasty

Study Details

The main objective of this study is to confirm long-term safety, performance, and clinical benefits of the Vivacit-E Vitamin E HXLPE Elevated Liners when used in primary total hip arthroplasty.

Key Dates

Start date
Jan 7, 2026
Status verified
Mar 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
52 participants (estimated)

Arms

  • Arm: Vivacit-E Elevated Liners
    Patients previously implanted with Vivacit-E Elevated Liners.

Primary Outcome Measure

Survival of the Implant System via Adverse Events [ Time Frame: 10 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
South Bend OrthopaedicsSouth BendIndiana46635-

Find similar trials in South Bend, IN

By research site
South Bend Orthopaedics· South Bend, IN

Related Studies